entity

Arimoclomol

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Arimoclomol: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

20Connections

0Hypotheses

0Analyses

16Outgoing

4Incoming

0Experiments

Wiki Pages (20)

Knowledge base pages for this entity

Outgoing (16)

Target	Relation	Type	Str
Amyotrophic Lateral Sclerosis	treats	disease	0.75
TDP-43	causes	gene	0.65
SOD1	activates	gene	0.65
MOTOR NEURONS	activates	cell_type	0.65
Als	treats	disease	0.60
TDP-43	associated_with	gene	0.45
FUS	associated_with	gene	0.45
SOD1	associated_with	gene	0.45
RILUZOLE	associated_with	drug	0.45
TFEB	associated_with	gene	0.45
NEURONS	associated_with	cell_type	0.45
NEURON	associated_with	cell_type	0.45
SPINAL CORD	associated_with	brain_region	0.45
CORTEX	associated_with	brain_region	0.45
GLUTAMATE	associated_with	phenotype	0.45
AUTOPHAGY	associated_with	phenotype	0.45

Incoming (4)

Source	Relation	Type	Str
AMYOTROPHIC LATERAL SCLEROSIS	associated_with	disease	0.45
MOTOR NEURONS	associated_with	cell_type	0.45
OXIDATIVE STRESS	associated_with	phenotype	0.45
NEURODEGENERATION	associated_with	disease	0.45

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Arimoclomol

Understanding Entity Pages

Wiki Pages (20)

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

ALS Failed Approaches Analysis

Niemann-Pick Disease Type C (NPC)

Pre-symptomatic Conversion Windows in ALS Genetic Risk Carriers

Proteostasis Network Dysfunction Comparison Across Neurodegenerative Diseases

Heat Shock Protein Response Pathway in Neurodegeneration

Shared Proteinostasis Failure in Alzheimer's and Parkinson's Disease

SOD1 Protein

Chaperone-Mediated Autophagy in Neurodegeneration

tdp-43-fus-rna-proteinopathy-comparison

Chaperone-Mediated Proteostasis Disease Comparison

chaperone-mediated-autophagy-parkinsons

Autophagy-Impaired Neurons

ALS-FTD-Parkinsonism Comparison Matrix

Protein Aggregation in Neurodegeneration

Section 204: Advanced Proteostasis and Protein Quality Control in CBS/PSP

Niemann-Pick Disease Treatment

αB-Crystallin (CRYAB)